BP 2023010659720

Pathology and Imaging
SOHRABI DEHNAVI, FARHAD

16 KERRY ST, ATHELSTONE. 5076
Phone: 0881651558
Birthdate: 23/03/1959 Sex: M Medicare Number: 33832606942
Your Reference: 00147092 Lab Reference: 23-74011515-HAE-0
Laboratory: AUSTRALIAN CLINICAL LABS
Addressee: DR BABAK TAGHAVI ARDEBILI Referred by: DR BABAK TAGHAVI ARDEBILI
Copy to:
DR NATALIE GILES
Name of Test: ROUTINE HAEMATOLOGY

Requested: 23/09/2022 Collected: 04/01/2023 Reported: 04/01/2023 15:34
CLINICAL NOTES: on Levothyroxin; secondary hyperparathyroidism
HAEMATOLOGY SPECIMEN: WHOLE BLOOD
Date: 04/01/23 07/10/21 19/02/21 (# Refers to current

Coll. Time: 08:55 08:55 08:35 result only)
Lab Number: 74011515 56051613 48750979
-------------------------------------------------------------------------
HAEMOGLOBIN 137 143 138 (125 - 175) g/L
RBC 5.01 5.30 5.15 (4.50 - 6.50)x10 ^12 /L
HCT 0.40 0.43 0.43 (0.40 - 0.55)
MCV 80 82 83 (80 - 99) fL
MCH 27.3 27.0 * 26.8 (27.0 - 34.0)pg
MCHC 342 329 323 (310 - 360) g/L
RDW 13.7 14.1 13.9 (11.0 - 15.0)%
WCC 7.3 7.9 7.7 (4.0 - 11.0) x10 ^9 /L
Neutrophils 2.9 3.4 3.5 (2.0 - 8.0) x10 ^9 /L
Lymphocytes 3.5 3.7 3.5 (1.0 - 4.0) x10 ^9 /L
Monocytes 0.6 0.5 0.5 (< 1.1) x10 ^9 /L
Eosinophils 0.2 0.2 0.2 (< 0.7) x10 ^9 /L
Basophils < 0.1 < 0.1 < 0.1 (< 0.3) x10 ^9 /L
PLATELETS 243 250 280 (150 - 450) x10 ^9 /L
ESR 12 (1 - 15) mm/h
#74011515 : No significant FBE abnormality.
CRP-W GHB-W OHD-W PTH-W BFO-W IS-W FBE-C ESR-C MBA-R LIP-R
This request has other tests in progress at the time of reporting

Phone: 0881651558
Your Reference: 00147092 Lab Reference: 23-74011515-CRP-0
Copy to:
DR NATALIE GILES
Name of Test: C-REACTIVE PROTEIN

BIOCHEMISTRY
C REACTIVE PROTEIN (CRP) SPECIMEN: SERUM
Date Time Lab No. CRP Units Ref. Range

-------------------------------------------------------------------------
04/01/23 08:55 74011515 * 7.6 mg/L (< 3.0)
In the setting of infection, CRP levels >100 mg/L are supportive of

bacterial rather than viral aetiology.
Note results from this CRP assay should not be used for cardiac risk
assessment. Please request the high sensitivity assay (hsCRP) instead.
CRP-C GHB-W OHD-W PTH-V BFO-W IS-W FBE-R ESR-R MBA-R LIP-R

Phone: 0881651558
Your Reference: 00147092 Lab Reference: 23-74011515-OHD-0
Copy to:
DR NATALIE GILES
Name of Test: VITAMIN D

ENDOCRINOLOGY
VITAMIN D SPECIMEN: SERUM
25-hydroxy
Date Req. No. Vitamin D
--------------------------------------------------------------------------
04/01/23 74011515 56 nmol/L
07/10/21 56051613 63
19/02/21 48750979 * 45
74011515 History of hyperparathyroidism.

Within normal limits.
Interpretation:
Vitamin D deficiency <50 nmol/L
Severe deficiency <20 nmol/L
COMMENT: Vitamin D sufficiency is defined as greater than or equal to

50 nmol/L at the end of winter (level may need to be 10-20 nmol/L higher
at the end of summer).
Reference: Position Statement. Vitamin D and Health in Adults in

Australia and New Zealand. MJA,196(11): 686-687, 2012.
CRP-C GHB-W OHD-C PTH-V BFO-W IS-C FBE-R ESR-R MBA-R LIP-R

Phone: 0881651558
Your Reference: 00147092 Lab Reference: 23-74011515-BFM-0
Copy to:
DR NATALIE GILES
Name of Test: B12, FOLATE (SERUM/RBC)

CLINICAL NOTES: on Levothyroxine;secondary hyperparathyroidism
BIOCHEMISTRY
VITAMIN B12 AND FOLATE SPECIMEN: SERUM/BLOOD
Date: 04/01/23
Time: 08:55
Lab Number: 74011515
---------------------------------------------------------------------------
Vitamin B12 299 pmol/L
Active B12 133 (> 30) pmol/L
Folate 36.3 nmol/L
74011515 Normal B12 and folate results.
RANGES B12 Serum Folate Red Cell Folate

Normal > 180 > 10.0 > 450
Equivocal 150 - 180 5.0 - 10.0 350 - 450
Deficient < 150 < 5.0 < 350
Vitamin B12 and Folate analyses are performed on the Siemens Centaur/
Atellica.
CRP-R GHB-W OHD-R PTH-R BFO-C IS-R FBE-R ESR-R MBA-R LIP-R

Phone: 0881651558
Your Reference: 00147092 Lab Reference: 23-74011515-GHB-0
Copy to:
DR NATALIE GILES
Name of Test: GLYCATED HAEMOGLOBIN

BIOCHEMISTRY
HAEMOGLOBIN A1c SPECIMEN: WHOLE BLOOD
IFCC DCCT
Date Coll Time Req. No. HbA1c (mmol/mol) HbA1c (%)
--------------------------------------------------------------------------
04/01/23 08:55 74011515 43 6.1
05/02/20 08:45 30584318 44 6.2
74011515 HbA1c consistent with euglycaemic state.
INTERPRETATION CRITERIA
DIAGNOSIS.
A HbA1c greater than or equal to 48 mmol/mol ( 6.5 %) is consistent
with diabetes
MONITORING.
The usual treatment target is less than or equal to 53 mmol/mol (7%) but
may vary depending on the clinical situation.
Please note that Hb A1c results may be influenced by conditions
affecting red cells or their survival times such as haemoglobinopathies,
anaemias, recent transfusion or blood loss.
CRP-R GHB-C OHD-R PTH-R BFO-R IS-R FBE-R ESR-R MBA-R LIP-R
All tests on this request have now been completed

Phone: 0881651558
Your Reference: 00147092 Lab Reference: 23-74011515-MBI-0
Copy to:
DR NATALIE GILES
Name of Test: GENERAL CHEMISTRY

GENERAL CHEMISTRY SPECIMEN: SERUM
Date: 04/01/23 07/10/21 19/02/21

Coll. Time: 08:55 08:55 08:35
Lab Number: 74011515 56051613 48750979
--------------------------------------------------------------------------
Sodium 140 142 139 (135 - 145) mmol/L
Potassium 3.7 3.7 3.8 (3.5 - 5.2) mmol/L
Chloride 103 102 103 (95 - 110) mmol/L
Bicarbonate 32 * 34 28 (22 - 32) mmol/L
Urea 8.9 * 10.8 * 10.0 (4.0 - 9.0) mmol/L
Creatinine * 143 * 140 * 134 (60 - 110) umol/L
eGFR * 45 * 46 * 48 (> 59) mL/min/1.73m2
Urate 0.36 * 0.50 * 0.51 (0.18 - 0.47) mmol/L
Calcium 2.11 2.27 2.13 (2.10 - 2.60) mmol/L
Adj. Ca. 2.15 2.31 2.15 (2.10 - 2.60) mmol/L
Phosphate 1.38 1.32 1.36 (0.75 - 1.50) mmol/L
T.Protein 74 77 74 (60 - 81) g/L
Albumin 37 37 39 (35 - 50) g/L
Globulin 37 * 40 35 (23 - 39) g/L
ALP 81 80 69 (40 - 130) U/L
Bilirubin 5 7 7 (< 25) umol/L
GGT 34 26 25 (< 51) U/L
AST 30 21 22 (< 41) U/L
ALT * 60 26 27 (< 51) U/L
LD 133 141 153 (50 - 280) U/L
Glucose 5.8 5.1 (see below) mmol/L
Cholesterol 5.6) mmol/L
Glucose Reference Ranges

Random 3.0 - 6.9 mmol/L
Fasting 3.0 - 5.4 mmol/L
The glucose result has been produced on a non-preserved sample.

74011515 History of hyperparathyroidism.
ELECTROLYTES
Elevated creatinine is most likely due to renal impairment.
LIVER FUNCTION
Consistent with mild hepatocellular damage.
CRP-W GHB-W OHD-W PTH-W BFO-W IS-W FBE-W ESR-W MBA-C LIP-C

Phone: 0881651558
Your Reference: 00147092 Lab Reference: 23-74011515-LS-0
Copy to:
DR NATALIE GILES
Name of Test: LIPID STUDIES

BIOCHEMISTRY
LIPID STUDIES SPECIMEN: SERUM
Date: 04/01/23 07/10/21 19/02/21 Desirable Range

Lab Number: 74011515 56051613 48750979 (Fasting)
--------------------------------------------------------------------------
Fasting Status Fasting Fasting Fasting
Total Chol. 5.0 5.3 5.5 (< 5.6) mmol/L
HDL Chol. * 0.8 * 0.8 * 0.8 (> 1.0) mmol/L
LDL Chol. * 3.2 * 3.4 * 3.5 (< 2.5) mmol/L
Non-HDL Chol. * 4.2 * 4.5 * 4.7 (< 3.9) mmol/L
Triglyceride * 2.2 * 2.3 * 2.5 (< 2.0) mmol/L
LDL/HDL Ratio 4.0 4.3 4.4

Chol/HDL Ratio 6.2 6.6 6.9
74011515 Mild increases in LDL-cholesterol and triglyceride in

association with low HDL-cholesterol. Interpret in conjunction with other
cardiovascular risk factors.
Desirable ranges for high CV risk patients are:

LDL Cholesterol < 2.0 mmol/L
Non-HDL Cholesterol <2.5 mmol/L
CRP-W GHB-W OHD-W PTH-W BFO-W IS-W FBE-W ESR-W MBA-C LIP-C

Phone: 0881651558
Your Reference: 00147092 Lab Reference: 23-74011515-ISM-0
Copy to:
DR NATALIE GILES
Name of Test: IRON STUDIES

BIOCHEMISTRY
IRON STUDIES SPECIMEN: SERUM
Date: 04/01/23
Lab Number: 74011515
---------------------------------------------------------------------------
Iron * 9 (10.0 - 30.0) umol/L
Transferrin 2.79 (2.10 - 3.80) g/L
Saturation * 13 (15 - 50) %
Ferritin 88 (30 - 500) ug/L
74011515 Elevated CRP noted. Low serum iron but ferritin within normal
range. Ferritin is not a good index of iron stores in the presence of
inflammation. More reliable assessment can be obtained after recovery
from intercurrent illness.
CRP-C GHB-W OHD-C PTH-V BFO-W IS-C FBE-R ESR-R MBA-R LIP-R

Phone: 0881651558
Your Reference: 00147092 Lab Reference: 23-74011515-PTH-0
Copy to:
DR NATALIE GILES
Name of Test: PARATHYROID HORMONE

ENDOCRINOLOGY
PARATHYROID HORMONE SPECIMEN: SERUM
Date Req. No. PTH Units Ref. Range

--------------------------------------------------------------------------
04/01/23 74011515 * < 0.3 pmol/L (2.0 - 8.5)
74011515 History of hypoparathyroidism.

Normal vitamin D noted.
Validated by B. Sonza
CRP-C GHB-W OHD-C PTH-C BFO-W IS-C FBE-R ESR-R MBA-R LIP-R

BP 2023010659720

Uploaded by

Document Information

Original Description:

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

BP 2023010659720

Uploaded by

Copyright:

Available Formats

Pathology and Imaging

SOHRABI DEHNAVI, FARHAD

Name of Test: ROUTINE HAEMATOLOGY

CLINICAL NOTES: on Levothyroxin; secondary hyperparathyroidism

HAEMATOLOGY SPECIMEN: WHOLE BLOOD

Date: 04/01/23 07/10/21 19/02/21 (# Refers to current

#74011515 : No significant FBE abnormality.

This request has other tests in progress at the time of reporting

Name of Test: C-REACTIVE PROTEIN

CLINICAL NOTES: on Levothyroxin; secondary hyperparathyroidism

C REACTIVE PROTEIN (CRP) SPECIMEN: SERUM

Date Time Lab No. CRP Units Ref. Range

In the setting of infection, CRP levels >100 mg/L are supportive of

This request has other tests in progress at the time of reporting

Name of Test: VITAMIN D

CLINICAL NOTES: on Levothyroxin; secondary hyperparathyroidism

VITAMIN D SPECIMEN: SERUM

74011515 History of hyperparathyroidism.

COMMENT: Vitamin D sufficiency is defined as greater than or equal to

Reference: Position Statement. Vitamin D and Health in Adults in

This request has other tests in progress at the time of reporting

Name of Test: B12, FOLATE (SERUM/RBC)

VITAMIN B12 AND FOLATE SPECIMEN: SERUM/BLOOD

74011515 Normal B12 and folate results.

RANGES B12 Serum Folate Red Cell Folate

This request has other tests in progress at the time of reporting

Name of Test: GLYCATED HAEMOGLOBIN

CLINICAL NOTES: on Levothyroxine;secondary hyperparathyroidism

HAEMOGLOBIN A1c SPECIMEN: WHOLE BLOOD

74011515 HbA1c consistent with euglycaemic state.

All tests on this request have now been completed

Name of Test: GENERAL CHEMISTRY

CLINICAL NOTES: on Levothyroxin; secondary hyperparathyroidism

GENERAL CHEMISTRY SPECIMEN: SERUM

Date: 04/01/23 07/10/21 19/02/21

Glucose Reference Ranges

The glucose result has been produced on a non-preserved sample.

This request has other tests in progress at the time of reporting

Name of Test: LIPID STUDIES

CLINICAL NOTES: on Levothyroxin; secondary hyperparathyroidism

LIPID STUDIES SPECIMEN: SERUM

Date: 04/01/23 07/10/21 19/02/21 Desirable Range

Triglyceride * 2.2 * 2.3 * 2.5 (< 2.0) mmol/L

LDL/HDL Ratio 4.0 4.3 4.4

74011515 Mild increases in LDL-cholesterol and triglyceride in

Desirable ranges for high CV risk patients are:

This request has other tests in progress at the time of reporting

Name of Test: IRON STUDIES

CLINICAL NOTES: on Levothyroxin; secondary hyperparathyroidism

IRON STUDIES SPECIMEN: SERUM

This request has other tests in progress at the time of reporting

Name of Test: PARATHYROID HORMONE

CLINICAL NOTES: on Levothyroxine;secondary hyperparathyroidism

PARATHYROID HORMONE SPECIMEN: SERUM

Date Req. No. PTH Units Ref. Range

74011515 History of hypoparathyroidism.

This request has other tests in progress at the time of reporting

You might also like